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Abstract
The purpose of this study was to assess the accuracy of absolute cerebral blood flow (CBF) measurements obtained by
dynamic contrast-enhanced (DCE) near-infrared spectroscopy (NIRS) using indocyanine green as a perfusion contrast
agent. For validation, CBF was measured independently using the MRI perfusion method arterial spin labeling (ASL). Data
were acquired at two sites and under two flow conditions (normocapnia and hypercapnia). Depth sensitivity was
enhanced using time-resolved detection, which was demonstrated in a separate set of experiments using a tourniquet
to temporally impede scalp blood flow. A strong correlation between CBF measurements from ASL and DCE-NIRS was
observed (slope ¼ 0.99  0.08, y-intercept ¼ 1.7  7.4 mL/100 g/min, and R2 ¼ 0.88). Mean difference between the two
techniques was 1.9 mL/100 g/min (95% confidence interval ranged from 15 to 19 mL/100g/min and the mean ASL CBF
was 75.4 mL/100 g/min). Error analysis showed that structural information and baseline absorption coefficient were
needed for optimal CBF reconstruction with DCE-NIRS. This study demonstrated that DCE-NIRS is sensitive to
blood flow in the adult brain and can provide accurate CBF measurements with the appropriate modeling techniques.
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Introduction
Monitoring cerebrovascular health is central to the
management of critical-care patients because of the
brain’s reliance on cerebral blood ﬂow (CBF) for a
continuous supply of oxygen and nutrients.1 This reliance has been demonstrated in animal stroke models in
which the severity of brain injury could be directly
linked to the magnitude and duration of reduced
CBF.2 Clinically, the importance of maintaining adequate CBF is well appreciated since delayed cerebral
ischemia (DCI) is a major cause of secondary brain
injury in patients under neurointensive care.3 This is
perhaps best exempliﬁed by subarachnoid hemorrhage
(SAH), which is one of the most life-threatening acute
neurological diseases. Even after an aneurysm is
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secured, DCI develops in one-third of patients within
the ﬁrst two weeks.4 The prevalence of DCI has led to
treatments focused on maintaining adequate CBF such
as ventricular drainage to alleviate intracranial pressure
(ICP) and the use of pharmacological vasodilators (e.g.
nimodipine).5
Cerebral perfusion is commonly assessed by
dynamic contrast-enhanced (DCE) imaging using
either computed tomography (CT) or magnetic resonance imaging (MRI).6 Unfortunately, transporting critical-care patients to imaging facilities is risky and
complicated and thus, severely reduces the frequency
of assessments.7 Transcranial Doppler provides bedside
monitoring of blood velocity in large cerebral arteries.
However, its accuracy is operator dependent, the signal
cannot be found in 30% of patients, and velocity in the
main arteries is an indirect measure of tissue perfusion.8
These limitations highlight the need to develop a
minimally invasive method for assessing cerebral
hemodynamics at the bedside.
Near-infrared spectroscopy (NIRS) is recognized as
a promising method for bedside neuromonitoring, principally because tissue oxygenation can be inferred from
the light-absorbing properties of hemoglobin. Cerebral
hemodynamics can also be assessed using the lightabsorbing dye indocyanine green (ICG) as an intravascular contrast agent, analogous to DCE CT and MRI.
ICG is a relatively nontoxic dye that is used clinically as
an optical marker of liver function, in ophthalmology
and to identify tumor margins during surgery.9–11
Results of previous studies have shown that ICG
doses typically administrated to animals and humans
have no toxic eﬀects on neuronal cells,12 and the most
common side-eﬀect is a possible allergic reaction.13
Therefore, adequate resuscitation facilities and properly trained personnel must be available when the dye
is injected. Because of its high absorption properties,
ICG can be used as a contrast agent for assessing
CBF.14 Like all optical methods, however, the main
limitation of adopting this technique in clinical practice
arise due to signal contamination from light absorption
in extracerebral tissues. Without correcting for this
limitation, DCE-NIRS has been shown to underestimate CBF by more than 50%.15,16
One approach to enhance the depth sensitivity of
reﬂectance measurements is time-resolved (TR) detection since late-arriving photons travel farther (i.e.
deeper) and therefore have a higher probability of interrogating the brain. DCE-NIRS has been adapted to TR
detection and used to detect perfusion deﬁciencies in
patients with intracerebral hematoma, acute ischemic
stroke and posttraumatic edema.17–21 In all of these
studies, a time series of the distribution of timesof-ﬂight (DTOF) of photons recorded after a bolus
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injection of ICG was characterized in terms of statistical moments (number of photons, N; mean time-ofﬂight, <t>; and variance, V), since higher moments are
weighted towards late-arriving photons. The validity of
this approach was supported by a study involving pigs
with a scalp/skull layer comparable in thickness to
adult humans.22 ICG kinetic curves based on <t > and
V derived from probes placed on the scalp were similar
in shape to those acquired directly on the brain.
Quantiﬁcation of CBF requires converting the timevarying absorption changes into an ICG concentration
curve and applying the principles of indicator dilution.23 Good agreement between CBF measurements
from DCE-NIRS and DCE CT was reported in an initial validation study involving pigs.24
Previous studies involving patients and animal
models provide strong evidence that DCE-NIRS combined with depth-enhanced TR detection can measure
CBF accurately in adult humans. The primary purpose
of the present study was to derive a benchmark comparison of CBF in healthy participants measured by the
MRI perfusion technique, arterial spin labeling (ASL),
and the optical ICG-bolus technique based on TR
NIRS.25 The study involved a series of experiments
acquired at two sites (Western University and the
University of Pennsylvania, UPenn). Under the
Western protocol, TR-NIRS data were acquired while
participants were in the MRI scanner to provide
simultaneous measurements. Data were acquired
at normocapnia and hypercapnia to determine if
DCE-NIRS was sensitive to the expected CBF increase
caused by the latter. In a separate experiment, the inﬂuence of scalp contamination was assessed by acquiring
ICG curves with and without inﬂating a tourniquet
placed around the head to cause transient scalp ischemia. For the UPenn protocol, DCE-NIRS and ASL
data were collected sequentially at normocapnia. This
enabled a series of injections with diﬀerent amounts of
ICG to be administered to investigate the relationship
between the optical signal and the contrast agent dose.
ASL was selected for this comparison study because it
can measure CBF accurately in the healthy brain and is
well suited to tracking perfusion changes caused by
hypercapnia.26,27

Materials and methods
ASL validation experiment (Western protocol)
Ten healthy subjects (three females, seven males, aged
22 to 54 y, mean ¼ 30  11 y) with no history of any
neurological or psychiatric disorders were recruited.
Written informed consent was obtained from all participants and all protocols/procedures were approved
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by the Western University Health Sciences Research
Ethics Board, which adheres to the guidelines of the
Tri-Council Policy Statement (TCPS), Ethical
Conduct for Research Involving Humans.
Experimental design. Experiments were performed using
a 3T Biograph mMR scanner (Siemens Medical
Systems, DE) using a 12-channel head coil. The head
was immobilized with foam padding to minimize
motion artifacts. The TR-NIRS optodes were held on
a subject’s forehead using a 3D-printed holder made of
NinjaFlexß (NinjaTek, PA). MRI ﬁducial marks were
placed on the holder to identify the location of the
optodes on structural MRIs. A catheter was inserted
into an arm vein for injecting ICG and a clip for dye
densitometry attached to a ﬁnger to measure the arterial ICG concentration. A nonrebreathing facemask
attached to a large non-diﬀusible gas reservoir bag
(Hans Rudolph Inc., MO) was used to deliver an air/
CO2 mixture (6% CO2, 21% O2, balance N2) to induce
hypercapnia. A line connected to the mask recorded
end-tidal partial pressure of CO2 (PETCO2) (Invivo
Expression MR400, Invivo Corp., FL).
Simultaneous DCE-NIRS and ASL data sets were
collected at baseline (i.e. normocapnia) and hypercapnia. For the baseline measurements, ASL data were
acquired continuously while subjects breathed room
air for 5 min and at the 3-minute mark, a bolus of
ICG was rapidly injected in less than 2 s. Each bolus
consisted of 2.4 mL solution of 25 mg of ICG dissolved
in 10 mL of saline. Because of diﬀerences in weight
across subjects (60 to 120 kg), the injected dose varied
from 0.05 to 0.1 mg/kg. There was a delay of at least
15 min between the end of the baseline acquisition and
the start of the hypercapnia protocol to allow for ICG
clearance. The hypercapnia protocol consisted of 7 min
of ASL acquisition starting with the subjects breathing
room air. Hypercapnia was induced by switching to the
air/CO2 mixture at the 2-min mark, which continued
for the remaining 5 min. The second ICG bolus injection was administered 3 min after the start of CO2
inhalation to allow suﬃcient time for CBF to reach a
new steady state.27 DTOFs were acquired continuously
at a sampling frequency of 3 Hz and for a duration of
90 s to capture the cerebral kinetics of the dye.
Concurrently, the time-varying arterial concentration
of ICG was measured on the subject’s ﬁnger by dye
densitometry (DDG-2001, Nihon Kohden, JP).
MRI acquisition. Sagittal T1-weighted images were
acquired using a 3D magnetization-prepared rapid gradient-echo (MPRAGE) sequence (repetition time
(TR) ¼ 2000 ms, echo time (TE) ¼ 2.98 ms and inversion
time (TI) ¼ 900 ms, ﬂip angle ¼ 9 , ﬁeld of view
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(FOV) ¼ 256  256 mm, isotropic voxel size ¼ 1.0 mm3).
ASL images were acquired using a transverse 2D gradient-echo echo planar imaging (EPI) sequence (TR/
TE ¼ 3500/12 ms, FOV ¼ 240  240 mm, 12 slices,
voxel size ¼ 3.8  3.8  6 mm, bandwidth ¼ 2298 Hz/
pixel). A pseudo-continuous labeling method was
used with the labeling plane set 9 cm below the center
of the imaging volume, a labeling duration of 1.5 s and
a post-label delay of 1 s. A nonselective inversion pulse
was applied during the post-label delay for background
suppression. For CBF quantiﬁcation, a proton density
scan (M0) was acquired with the same sequence using a
TR of 7 s and no labeling or background suppression
pulses.
DCE NIRS. The TR-NIRS system was built in-house
and is described in detail elsewhere.28 Picosecond
pulses from a single laser emitting at k ¼ 803 nm were
transmitted to the surface of the subject head using 8-m
long ﬁber ( ¼ 200 lm, NA ¼ 0.39, FT200UMT,
Thorlabs, NJ). Diﬀusely reﬂected light was measured
at source-detector separations (rSD) of 1 and 4 cm using
an 8-m ﬁber at 1 cm ( ¼ 62.5 lm, NA ¼ 0.275, GIF625,
Thorlabs, NJ) and an 8-m ﬁber bundle at 4 cm
( ¼ 3.2 mm, NA ¼ 0.25, Fiberoptics Technology, CT).
The output of each was coupled to a hybrid photomultiplier tube (Hybrid 50, PicoQuant, Germany).
The instrument response function (IRF) was measured
according to Liebert et al.29

Scalp contamination experiments
Experiments were conducted on a subset of ﬁve participants from the validation experiments (one female, four
males, mean age ¼ 28  4 y). Each experiment was performed in a dark room with the participant sitting in a
reclining posture with the optodes positioned on the
forehead at rSD ¼ 1, 3, and 4 cm ( ¼ 3.6 mm,
NA ¼ 0.55, Fiberoptics Technology, CT). A pneumatic
tourniquet was wrapped around the head just above the
ears. It had a 10 cm slit positioned around the optode
holder to avoid any pressure on the holder when
inﬂated. Two sets of ICG data were acquired following
the same DCE protocol outlined above, one prior to
and the other after inﬂating the tourniquet to
200 mmHg. There was a delay of 20 min between injections to enable ICG clearance.

ASL validation experiment (UPenn protocol)
Seven healthy participants were studied (four females,
three males, age ¼ 26  4 years). Written consent for all
subjects was provided by legally authorized representatives, and all protocols/procedures were approved by
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the institutional review board at the University of
Pennsylvania, which adheres to the guidelines of the
Common Rule and the Food and Drug
Administration’s Institutional Review Board and
human subject regulations.
Experimental design. Experiments were carried out in two
steps: (1) A series of DCE NIRS data were ﬁrst
acquired with varying ICG bolus concentrations; (2)
CBF imaging with ASL. Step one was performed in
the MRI anteroom. An intravenous cannula was
placed in the subject’s arm for injecting ICG. The
TR-NIRS optodes were secured above the frontoparietal cortex (marked with pens), and a customized DDG
was secured to the subject’s index ﬁnger to measure the
arterial ICG concentration.20 A series of ICG boluses
(0.02, 0.04, 0.08, and 0.16 mg/kg) were rapidly injected
(<2 s), while the subject lied supine (note, the appropriate volume of a 2.5 mg/mL stock solution was injected
to achieve the desired mg/kg dose). For each injection,
the TR-NIRS and DDG data were acquired for 4 min
(2 min prior and 2 min after injection); there was a delay
of 5 min between injections.
After acquisition of the DCE-NIRS data sets, the
subject was moved into the MRI scanner while remaining supine with ﬁducial markers on the forehead indicating the position of TR-NIRS probes. MRI
experiments were performed using a 3T Siemens
Prisma scanner (Siemens Medical Systems, DE) using
a 64-channel Head/Neck coil.
MRI acquisition. High-resolution T1-weighted MPRAGE
images were collected (TR ¼ 1810 ms, TE ¼ 3.51 ms,
TI ¼ 1100 ms, ﬂip angle ¼ 9 , bandwidth ¼ 130 Hz/px,
isotropic voxel size ¼ 1 mm3, FOV ¼ 192  256 mm2,
160 slices). Perfusion images were acquired with an
unbalanced pCASL technique with a labeling time
of 1.8 s and a post-labeling delay of 1.8 s. The position
of the labeling plane was based on time-of-ﬂight
angiography.30 Data were acquired with 2-shot 3D
spiral acquisition with TR ¼ 4.5 s, TE ¼ 10.19 ms,
matrix ¼ 64  64, 90% background suppression, isotropic voxel resolution of 3.75 mm3, ﬂip angle ¼ 90 ,
FOV ¼ 240 mm, pixel bandwidth ¼ 400 Hz/px. Two
volumes of M0 images were acquired for CBF
quantiﬁcation.
DCE NIRS. Details regarding the TR-NIRS instrumentation and optical probe are described elsewhere.20
Brieﬂy, a supercontinuum ﬁber laser (NKT Photonics
Inc., New Jersey) was used to generate light pulses
centred at 808 nm (78 MHz). Two hybrid photomultiplier tubes (Hybrid 50, PicoQuant, Germany)
acquired light at rSD ¼ 0.7 and 3.2 cm and at a sampling
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rate of 0.9 Hz. The instrument response function was
measured shortly after the ASL scan.

ASL image analysis
Similar analyses of ASL data were performed at both
sites using a combination of MATLAB (Mathworks
Inc., MA), SPM8 or SPM12 (www.ﬁl.ion.ucl.ac.uk),
and FSL.27,31 ASL time series and M0 images were
aligned to correct for head motion and subsequently
coregistered to the structural image. A time series of
perfusion-weighted (M) images was generated by
either surround subtraction (Western) or pairwise subtraction (UPenn). Mean CBF images were generated
using the standard single-compartment ﬂow model32
and by temporal averaging. For the UPenn data, averaging was performed using 25 label/control pairs. For
the Western data, each time series was separated into
baseline (60 pairs) and hypercapnia (26 pairs, acquired
during the last 3 min of CO2 inhalation to provide time
for CBF to reach steady state27). For the Western data,
the resulting normocapnia and hypercapnia CBF
images were smoothed using a Gaussian ﬁlter with a
FWHM of 12 mm.
For comparison with the CBF measurements from
DCE NIRS, masks of grey matter (GM), white matter
(WM) and cerebrospinal ﬂuid (CSF) were generated by
segmenting the corresponding T1-weighted images.
A GM mask was created by selecting only voxels with
80% or more GM content. The mask was applied to the
CBF images to extract mean cortical CBF estimates
from the two imaging slices closest to the location of
the NIRS optodes.

DCE NIRS analysis
The same analysis approach was applied to data from
both sites, which began by subtracting the background
signal from each DTOF in a time series. The background signal was deﬁned as the mean number of photons measured prior to the initial rise of the DTOF.
Next the statistical moments (N, <t> and V) were calculated and the resulting times series smoothed with a
5-s moving average.33 CBF was calculated using only
the <t> data measured at the long separation,
i.e. <t>L. Using <t>L alone represents a compromise
between the greater depth sensitivity provided by
higher moment analysis versus the reduction in signalto-noise with each successive moment.34,35 Moreover,
the scalp contamination experiments demonstrated
that <t> at rSD  3 cm was insensitive to scalp blood
ﬂow (see Results).
Determining CBF required converting the timevarying change in <t>L caused by the passage of ICG
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through the cerebral microvasculature, D<t>L(T), into
the corresponding change in the brain absorption coefﬁcient, Da,B(T), where T refers to the time scale of the
ICG experiment.17 A two-layer model of the head was
used that was composed of a semi-inﬁnite bottom layer
representing the brain with absorption and reduced
scattering coeﬃcients, a,B and s,B0 , respectively, and
an extracerebral top layer representing scalp and skull
with thickness (dC) and optical coeﬃcients denoted by
a,e and s,e0 . Each subject’s structural MRI was used
to measure dC, which was measured at the centre of the
optical probe.
Typically the relationship between D<t>L and Da,B
is assumed to be linear;17,24 however, our multi-dose
experiments (see Results) indicated that this assumption
is not valid for the absorption changes induced by the
ICG boluses (i.e. boluses> 0.08 mg/kg) used in the CBF
experiments. Accordingly, a third-order Taylor expansion of <t>L was used to relate D<t>L to Da,B(T).
Assuming that D<t>L(T) was not aﬀected by scalp
absorption changes, the relationship is given by
htiL ðTÞ ¼ B  a,B ðTÞ þ B  a,B ðTÞ2
þ B  a,B ðTÞ3

in the exclusion of one subject from Western and one
from UPenn.
For each subject, Da,B(T) was converted into cerebral tissue ICG concentration, CB(T), using the wavelength speciﬁc extinction coeﬃcient,38 eICG(k) (Western
protocol: 803 nm, 0.186 OD/lM/cm; UPenn protocol:
808 nm, 0.190 OD/lM/cm). Because baseline ICG concentration is zero, CB(T) ¼ eICG(k)Dla,B(T).39
The ﬁnal step was to determine CBF by indicator
dilution theory
CB ðTÞ ¼ CBF  RðTÞ  Ca ðTÞ

ð2Þ

where * is the convolution operator and Ca(T) is the
arterial ICG concentration curve measured by a DDG.
R(T) represents the ICG brain concentration for an
idealized bolus injection of unit concentration. Since
R(T ¼ 0) ¼ 1 by deﬁnition, the initial height of
CBFR(T), determined by the deconvolution,23 equals
CBF. Deconvolution was performed using the ﬁrst 45 s
of the ICG concentration curves as the ﬁrst pass of the
contrast agent provides the greatest sensitivity to blood
ﬂow.

ð1Þ

Statistical analysis
where , b, and c coeﬃcients are weighting factors that
were calculated numerically by taking the appropriate
derivative of the baseline <t> obtained from the
photon diﬀusion equation for a two-layer medium36,37
(see Supplementary Material).
At this stage, the analysis of the data from the two
sites deviated slightly. The 8-m long optical ﬁbers
required to collect DCE-NIRS and ASL data simultaneously at Western led to signiﬁcantly broadened the
IRF, making it diﬃcult to obtain accurate subject-speciﬁc optical properties. At UPenn, shorter optical
probes could be used since DCE-NIRS and ASL data
were acquired sequentially, resulting in a narrower
IRF. Consequently, B, bB, and cB, where determined
using baseline optical properties averaged across
subjects under the Western protocol (ao ¼ 0.17 cm1
and lso0 ¼ 8.0 cm1), while individual ao and so0
values were used under the UPenn protocol. The ﬁnal
step was to use the B, b B and cB values to convert
D<t>L(T) to Da,B(T) using equation (1).
To assess the sensitivity to the brain, the kinetics of
the measured D<t>L were compared to that for the
short separation (i.e. D<t>S). These two curves
should appear diﬀerent since scalp blood ﬂow is
expected to be lower than CBF. Speciﬁcally, the timeto-peak (TTP) of D<t>L and D<t>S data were computed, and any case wherein jTTPS-TTPLj < 0.6 sec was
excluded from further analysis. This criterion resulted

All data are presented as mean  standard deviation
unless otherwise noted. Statistical signiﬁcance was
deﬁned as p < 0.05. Linear regression analysis was performed on the CBF measurements from TR-NIRS and
ASL to examine the correlation between the two techniques. Student’s t-tests were used to assess if the
regression slope and intercept were diﬀerent from 1
and 0, respectively. Additionally, Bland–Altman analysis was conducted to access the similarity between
the two sets of CBF measurements. A paired t-test
was used to assess CBF diﬀerences between normoand hypercapnia, and before and after inﬂating the
head tourniquet (scalp contamination experiment).

Error analysis
Error analysis was conducted to investigate the sensitivity of the CBF estimates to changes in the input
parameters (ao, so0 , and dC) used to generate the
Taylor expansion coeﬃcients. For this purpose, data
sets from nine subjects were reanalyzed after varying
each input parameter by 20% to 20% from its original value. The Taylor coeﬃcients were recalculated
for every incremental change in an individual input
parameter and were subsequently used to convert
measured D<t>L to Da,B (i.e. equation (1)), from
which CBF was calculated via equation (2). The fractional diﬀerence between the CBF calculated for every
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incremental change and the original CBF value was
computed.

Results
Scalp contamination experiment
Time-varying changes in the photon count (DN) and
mean time-of-ﬂight (D<t>) in response to IV injections
of ICG are shown in Figure 1. These time courses were
averaged across the ﬁve subjects who participated in
this experiment. Data are presented for rSD ¼ 1, 3,
and 4 cm before and after inﬂating the tourniquet
wrapped around the head. At all source-detector distances, the average DN time series exhibited noticeable
diﬀerences before and after inﬂation. In contrast, differences were small between D<t> time series recorded
at rSD ¼ 3 and 4 cm pre and post tourniquet inﬂation,
while noticeable diﬀerence was observed at rSD ¼ 1 cm
(see Figure 1 zoomed in view). However, the eﬀects of
the tourniquet on the time series recorded at rSD ¼ 1 cm
were smaller for D<t> compared to DN, which can
likely be explained by diﬀerences in depth sensitivity.
That is, D<t> at this distance is more sensitive to the
skull than scalp, while the reverse is true for DN. CBF
was determined for the D<t> time series acquired at
rSD ¼ 3 and 4 cm, and no signiﬁcant diﬀerence was
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found between average values before and after inﬂating
the tourniquet (i.e. 63  14 and 66  16 mL/100g/min,
respectively at rSD ¼ 3 cm, and 67  6 and 68  10 mL/
100 g/min, respectively, at rSD¼4 cm). These results
indicate that D<t> acquired at rSD ¼ 3 and 4 cm was
insensitive to scalp ﬂow.

Time-of-flight measurements as a function of ICG
doses
The maximum change in <t> at the long separation,
D<t>L,max, is presented in Figure 2(a) as a function of
ICG dose. Each data point was averaged over four participants who had good quality TR data at all four doses
(three females, mean age ¼ 25  5 y). This ﬁgure demonstrates that the relation between D<t>L,max and ICG
dose was not linear. This was conﬁrmed by simulated
data (Figure 2(b)) generated using the two-layer head
model (i.e. equation (S3)) over a wide range of Dla,B
values (baseline optical properties: ao ¼ 0.12 cm1,
so ¼ 11 cm1, rSD ¼ 3.2 cm, and dC ¼ 1.4 cm).

Comparison of CBF measurements from DCE-NIRS
and ASL
Axial CBF images acquired at normocapnia and hypercapnia for a representative subject under the Western

Figure 1. Change in the number of photons (top row) and mean time-of-flight (bottom row) plotted as a function of time following
an intravenous bolus injection of ICG at time ¼ 0 s. Time courses acquired at three source-detector distances (rSD ¼ 1, 3, and 4 cm)
are shown before (black) and after (red) inflating the tourniquet (see Scalp Contamination Experiments protocol in Methods). Each
time series was averaged across five subjects, and the grey shadowing represents the standard deviation.
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Figure 2. (a) Average D<t>L,max across four subjects (mean  SD) plotted against ICG dose. The measurements deviate substantially from the expected linear relationship (red line) determined from the average D<t>L,max at the smallest dose (0.02 mg/kg), i.e. the
line connecting the origin with D<t>L,max at 0.02 mg/kg. (b) Simulated D<t>L,max plotted against Dla,Bmax from a two-layer head
model (blue circles). The simulated D<t>L,max values was generated using equation (S3) with ao ¼ 0.12 cm1, so ¼ 11 cm1,
rSD ¼ 3.2 cm, and dC ¼ 1.4 cm. The reconstructed D<t>L,max obtained by Taylor expansion (black line, B ¼ 0.91, b B ¼ 5.47, and
cB ¼ 29.92) agreed well with the simulated D<t>L,max, while the reconstructed D<t>L,max from a linear model (red line) was
substantially lower.

protocol are shown in Figure 3. This imaging slice corresponded to the location of the NIRS optodes.
Included in the ﬁgure are the arterial and tissue ICG
concentration curves acquired simultaneously under
the two capnic conditions.
Average normocapnic CBF measurements obtained
by DCE-NIRS and ASL for the two sites are reported in
Table 1. For the UPenn data, CBF was determined for
each subject using the ICG dose with best signal-to-noise
ratio for CB(T) and the data with minimum motion artifacts for Ca(T) (i.e. one subject at 0.04 mg/kg, three subjects at 0.08 mg/kg, one subject at 0.16 mg/kg). Table 1
also reports the average baseline tissue optical properties, the Taylor expansion coeﬃcients, and the dC measurements from the anatomical MRIs.
From the Western site, the average PETCO2
increased was 7.7  1.8 mmHg due to inhaling 6%
CO2. The average hypercapnic CBF measured by
ASL and DCE-NIRS were 109  21 and 107  18 mL/
100g/min, respectively. A signiﬁcant increase in CBF
caused by hypercapnia was measured by both techniques (p < 0.001).
Figure 4 shows the linear regression plot of CBF
data from DCE-NIRS and ASL. This ﬁgure includes
all data from both sites (nine from Western and ﬁve
from UPenn). Each data point represents a CBF estimate from a single ICG injection. The regression slope
was 0.99  0.08 (95% Conﬁdence Interval ¼ 0.16),
the square of the Pearson’s correlation coeﬃcient (R2)
was 0.88, and the intercept was 1.  7.4 mL/100g/min.
The slope was signiﬁcantly diﬀerent from the null

(p < 0.001), but not from the line of identity. Similar
results were obtained by analyzing the Western data
separately (slope ¼ 0.89  0.06, y-intercept ¼ 9.5 
6.0 mL/100g/min, and R2 ¼ 0.92). Although the
UPenn data does not have a suﬃcient sample size to
perform regression analysis based on an alpha of 0.05
and a power of 0.8, the slope of the best-ﬁt line to the
UPenn data with intercept forced to zero is 0.93  0.08,
which is similar to the Western data (see Supplementary
Material).
The corresponding Bland–Altman plot comparing
CBF measurements from the two techniques is shown
in Figure 5. Again, the analysis was conducted by pooling data from both sites. The average diﬀerence
between ASL and DCE-NIRS (1.9 mL/100g/min) was
not signiﬁcantly diﬀerent from the (p ¼ 0.32).

Error analysis
Figure 6 shows the results of the error analysis performed to investigate the sensitivity of CBF to changes
in the input parameters (ao, lso0 , and dC). Findings are
presented for nine subjects under the Western protocol.
The error in CBF due to varying ao by  20% ranged
from 38  9% to 50  23% at baseline and from
37  7% to 44  14% at hypercapnia. A similar magnitude of error was caused by varying dC by  20%:
41  10% to 61  31% at baseline and 39  6% to
54  19% at hypercapnia. By contrast, the estimated
CBF was rather insensitive to changes in lso0 under
both ﬂow conditions.
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Figure 3. (a) Structural MR image showing the location of the fiducial markers. CBF images acquired from one subject at (b)
normocapnia (mean grey matter CBF ¼ 67 mL/100g/min, PETCO2 ¼ 35.8 mmHg) and (c) hypercapnia (mean grey matter CBF ¼ 112 ml/
100g/min, PETCO2 ¼ 43.5 mmHg). Corresponding brain (black) and arterial (red) ICG concentration curves are shown in the bottom
row. For illustration purposes, the brain concentration curves were scaled by a factor of 20. Included in (d) and (e) are the derived
CBFR(T) function obtained by deconvolution. The grey shaded interval indicates the 45-second window used for the deconvolution.
The CBF estimates from the ICG data were 76 and 106 mL/100g/min at normo- and hypercapnia, respectively.

Table 1. Average baseline CBF, optical properties, Taylor expansion coefficients for the brain, and extracerebral layer thickness.
CBF

UPenn
Western

Parameters

NIRS
(mL/100 g/min)

ASL
(mL/100 g/min)

ao
(cm1)

so0
(cm1)

B
(nscm)

bB
(nscm2)

cB
(nscm3)

dC
(cm)

65.8  21.7
74.4  13.6

72.8  10.2
76.1  14.6

0.12  0.02
0.17  0.04

11.1  0.8
8.0  1.5

0.9  0.4
0.8  0.1

5.6  2.2
3.8  0.6

29.8  11.3
16.9  2.4

1.4  0.2
1.5  0.1

CBF: cerebral blood flow; NIRS: near-infrared spectroscopy; ASL: arterial spin labeling.

Discussion
The two main outcomes of this study were to show that
DCE-NIRS can accurately measure cortical blood ﬂow
in the adult human brain and that the technique is sensitive to changes in CBF. These outcomes were demonstrated by comparison to CBF measurements obtained
with ASL at normocapnia (Western and UPenn protocols) and hypercapnia (Western protocol) in healthy
adults. The results of the regression analysis showed a
strong correlation (slope ¼ 0.99 and R2 ¼ 0.88) between
CBF values from DCE-NIRS and ASL-MRI over
a range from 50 to 150 mL/100g/min (Figure 4).

This good agreement was conﬁrmed by the Bland–
Altman analysis, which revealed a nonsigniﬁcant bias
between the two methods of approximately 2 mL/100g/
min (Figure 5). This sensitivity to CBF beneﬁted from
two major factors: using TR detection to enhance depth
sensitivity and using a two-layer tissue head model to
estimate the signal contribution from the brain.

Enhanced depth sensitivity with TR detection
Enhanced depth sensitivity by using the mean timeof-ﬂight instead of the total photon count was demonstrated in the tourniquet experiments (Figure 1). Unlike
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the total photon count, the mean time-of-ﬂight for
rSD  3 cm showed little sensitivity to the passage of
ICG through the scalp. Only at the shortest separation
(rSD ¼ 1 cm), which will have the greatest sensitivity to
scalp blood ﬂow, did D<t> exhibit changes due to
inﬂating the tourniquet. By contrast, large diﬀerences
in the DN time series at all three rSD values were evident
before and after tourniquet inﬂation. This ﬁnding conﬁrms the predictions of sensitivity analysis and is in
agreement with animal studies showing the similarity
between ICG time courses from optodes placed directly
on the brain to those obtained on the scalp through the
analysis of higher moments.17,19,22 In addition, DCE-

Figure 4. Regression plot comparing CBF values from DCENIRS and ASL. Dashed lines are 95% confidence intervals, and
the solid line is the best-fit from linear regression
(slope ¼ 0.99  0.08, intercept ¼ 1.7  7.4 mL/100g/min and
R2 ¼ 0.88).
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NIRS simulation based on input parameters reﬂecting a
healthy adult receiving a 0.1 mg/kg ICG bolus (e.g.
CBF ¼ 60 mL/100g/min, a cerebral-to-scalp blood ﬂow
ratio of 6, dC ¼ 1.4 cm) predicted that neglecting the
extra-cerebral terms resulted in a 15% underestimation
in retrieved CBF (see Supplementary Material). This
prediction is moderately higher than observed in the
scalp contamination experiments, which is likely due
to discrepancies between the input parameters used in
the simulation versus the hemodynamic and optical
properties of a head.

Accurate estimation of <t> sensitivity to brain
In addition to improving depth sensitivity, the second
critical factor for measuring CBF was estimating the
signal contribution from the brain. Since the adult
head cannot be modeled accurately as a semi-inﬁnite
medium, determining CBF required accurately modeling the change in light absorption in the brain. For this
purpose, a two-layer model was used to generate the
sensitivity factors needed to convert an optical signal
change to Da,B.17,23 Generally, linear sensitivity factors are used for this step; however, this approach
was not valid for these experiments. The observed nonlinearity of D<t>L with respect to ICG concentration
diminished the expected signal change predicted by
a linear relationship (Figure 2). To address this issue,
a third-order Taylor expansion of <t>L was employed
to accurately model the relationship between D<t>L
and Da,B.
Alternatively, nonlinear modeling could be avoided
by limiting the ICG dose—albeit at the cost of reducing
contrast to noise ratio—or by deriving CB(T) from the
change in the number of photons (N). However, using

Figure 5. Bland–Altman plot comparing CBF measurements from DCE-NIRS and ASL. Date were grouped by site as described in
Figure 4. Mean difference between the two methods across data from both sites is indicated by the solid black line (1.9 mL/100 g/min),
which was bound by a 95% confidence interval of 15 to 19 mL/100 g/min.
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Figure 6. Predicted error in estimated CBF due to the use of erroneous input parameters used to generate the Taylor expansion
coefficients. The mean error values and standard deviation across subjects data at baseline (left column) and hypercapnia (right
column) are presented.

N/N0 comes at the cost of reduced depth sensitivity and
substantially greater scalp contamination. A scalp component could in principle be included in the modeling,
but inclusion will add complexity since the accuracy of
a CBF estimate will depend on properly characterizing
sensitivity functions for both scalp and brain layers.
The key simpliﬁcation enabled by the depth sensitivity of <t>L was neglecting extra-cerebral terms in equation (1). Experimental results (Figure 1) and simulations
(Supplementary Material) suggest this simpliﬁcation is
likely reasonable at long source-detector separations.
However, further work is needed to investigate the validity of this approach in patient populations with lower
CBF since the cerebral-to-scalp blood ﬂow ratio will be
reduced. We recommend that DCE data should continue to be collected at two distances in order to assess
if the single long-distance approach remains valid or if
the analysis has to be modiﬁed to incorporate scalp
contributions.
For further studies, practical issues should be considered regarding the selected ICG dose. Selection must
provide suﬃcient signal contrast for both NIRS and
dye densitometry. In our experience, doses below
0.04 mg/kg generally resulted in poor quality arterial
input functions measured by the DDG. In addition,
the selected dose should not be too large in order to
minimize the nonlinearity eﬀect shown in Figure 2(a).
Based on these considerations, the optimal dose is likely
between 0.05 to 0.08 mg/kg.
Finally, despite the general agreement between DCENIRS and ASL, our error analysis demonstrated that
the accuracy of the CBF estimates was highly dependent
on the input parameters ao, and dC used to generate the
sensitivity factors (Figure 6). The sensitivity to dC is perhaps not unsurprising considering that accurately

estimating Da,B(T) requires separating light propagation through the extracerebral and cerebral layers of the
head. For this study, dC was measured from each subject’s structural MRI. With respect to clinical translation, a priori anatomical measurements should be
available because patients with neurological emergencies will typically undergo either a CT or MRI. It
should be possible to measure dC directly by ultrasound,
which would facilitate a stand-alone approach.40
The sensitivity of the method to ao indicates that it
is desirable to measure the baseline optical properties
accurately. In the Western protocol, the patient-averaged ao and lso0 values were used because of large
inter-subject variability. This limitation can be attributed to the relatively wide IRF (800  115 ps) due to the
8-m ﬁbers required for simultaneous MRI/NIRS. Since
the IRF was comparable to the temporal width of the
measured DTOFs (1000  173 ps), the ﬁtting routines
used to derive ao and lso0 were sensitive to small
errors in the measured IRF and DTOF. Despite this
limitation, the good agreement between CBF values
from
NIRS
and
ASL
(slope ¼ 0.89  0.06,
y-intercept ¼ 9.5  6.0 mL/100g/min, and R2 ¼ 0.92)
indicates that the inter-subject variability in ao was
comparatively small. The average optical properties
were also in good agreement with a previous study
that measured ao (0.176  0.002 cm1) and lso0
(7.5  0.1 cm1) at 803 nm in newborn piglets.39
The IRF under the UPenn protocol was less than
200 ps due to the use of a supercontinuum laser
and shorter ﬁbers. Consequently, individual optical
properties were measured and used in the analysis.
In general, the variability between individual
ao values was small; however, ao for one participant
(0.09 cm1) was 30% lower than the group average.
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The NIRS CBF estimate for this participant was also
40% lower than from ASL (33 versus 54 mL/100g/min),
suggesting that an error in ao may have contributed to
the underestimation of CBF.
The sensitivity of the method to ao could present a
challenge to future clinical studies if factors such as
head injury caused signiﬁcant changes in baseline optical properties. Consequently, accurately accurate measurement of the optical properties of each individual will
be important, which will require robust and accurate
measurement of optical properties by TR NIRS in clinical settings. Future work is also needed to characterize
errors arising from the use of the same baseline optical
properties for brain and the superﬁcial tissue layer in
the two-layer head model, and thus to ascertain
whether more complex head models beyond two-layer
are needed in clinical patient populations.

Confirming adequate depth sensitivity to the brain
Another concern with the current study was the lack of
sensitivity to CBF found in two subjects, one from
Western and the other from UPenn. These data sets
were excluded because the ICG concentration curves
recorded at the longer rSD value (3.2 or 4 cm) were
very similar to those recorded at shorter rSD value
(0.7 or 1 cm), thereby suggesting a lack of sensitivity
to the faster kinetics of blood ﬂow in the brain relative
to scalp tissue. For the subject in the Western protocol,
this lack of depth sensitivity was attributed to poor
probe contact on the skin, as it was sometimes challenging to ensure the probes stayed in position once the
subject was moved into the MRI scanner. A similar
problem may have contributed to the subject’s data
acquired under the UPenn protocol, although the
experimental setup was simpler. Alternately, the lack
of sensitivity suggests that it would be advantageous
to use a larger source-detector separation (e.g. 4 cm),
higher order DTOF moments,42,43 or gated detection to
capture late-arriving photons44,45 and thereby increase
the sensitivity to the brain.

Other DCE-NIRS applications
While quantitative, DCE-NIRS is not conducive to
continuous monitoring since it requires a bolus injection of ICG. This limitation can be overcome by combining it with diﬀuse correlation spectroscopy (DCS).
In this scheme a single CBF measurement from DCENIRS is used to calibrate relative ﬂow data from
DCS.46 This approach can be extended to longitudinal
monitoring by generating a calibration curve between
CBF and the blood ﬂow index measured by DCS.20,47
However, measuring an absolute blood ﬂow index with
DCS also requires measuring a and s0 , and some
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method to account for scalp blood ﬂow, such as acquiring multi-distance DCS data.48,49
DCE-NIRS can also be used to measure blood–
brain barrier permeability and oxidative metabolism
when combined with tissue oxygenation data.28,50
Adapting these approaches to adult patients will
require careful assessment. Measuring permeability is
dependent on ICG clearance, which may be more
prone to scalp contamination since ICG is likely to
leak into scalp tissue due to the lack of tight conjunctions between endothelium cells. Likewise, tissue oxygenation requires measuring absolute a,B at multiple
wavelengths. Subtraction TR-NIRS, which uses higher
moment analysis of DTOFs collected at multiple
source-detector distances to enhance depth sensitivity,
is one approach that may be promising for isolating
a,B.42,43 Finally, it should be noted that an alternative
to TR NIRS would be the frequency-domain NIRS
since the measured phase change is directly proportional to the mean time-of-ﬂight.51,52

Conclusion
In summary, this is the ﬁrst study to show that DCE
NIRS, i.e. NIRS combined with depth-sensitive detection, can quantify CBF in healthy adults. The good
agreement, when compared to CBF measurements
from ASL, suggests this method could provide quantitative CBF data at the bedside of critically ill patients.
Further studies involving relevant patient populations
are needed to verify that DCE-NIRS can detect cerebral perfusion deﬁciencies.
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